Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study
- 29 March 2003
- Vol. 326 (7391) , 681
- https://doi.org/10.1136/bmj.326.7391.681
Abstract
Objective: To investigate the impact of an increase in blood glucose on the risk of developing myocardial infarction, with particular emphasis on people taking antihypertensive drugs. Design: Prospective population based cohort study. Setting: Uppsala, Sweden. Participants: 1860 men who had participated in 1970–3 at age 50 in a health survey aimed at identifying risk factors for cardiovascular disease and were re-examined at age 60 and then followed for 17.4 years. Main outcome measure: Myocardial infarction after age 60. Results: The incidence of myocardial infarction was significantly higher in men treated for hypertension than in those without such treatment (23% v 13.5%, PConclusions: Increase in blood glucose between the ages of 50 and 60 and baseline proinsulin concentration were important risk factors for myocardial infarction in men receiving antihypertensive treatment, indicating that both an insulin resistant state and the metabolic impact of β blockers and diuretics increase the risk of myocardial infarction. What is already known on this topic Patients with hypertension are resistant to insulin stimulated glucose uptake and are hyperinsulinaemic compared with normotensive controls Treatment with β blockers and thiazide diuretics further increases insulin resistance, thereby increasing the risk of developing type 2 diabetes mellitus or impaired glucose tolerance The influence of metabolic changes induced by antihypertensive treatment on the risk of myocardial infarction has been questioned What this study adds Men who received antihypertensive treatment showed a larger increase in blood glucose during a 10 year period than those without such treatment Increase in blood glucose during antihypertensive treatment was a significant, independent risk factor for myocardial infarction in men with an insulin resistant state at baselineKeywords
This publication has 25 references indexed in Scilit:
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJournal of the American College of Cardiology, 1996
- Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin SecretionDiabetic Medicine, 1994
- Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapyAmerican Heart Journal, 1991
- Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.BMJ, 1991
- Insulin resistance is a characteristic feature of primary hypertension independent of obesityMetabolism, 1990
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.BMJ, 1989
- Diabetes in patients with hypertension receiving pharmacological treatment.BMJ, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall StudyThe Lancet, 1980